Two Sigma Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-109,131
| Closed | -$11.1M | – | 3270 |
|
|
2023
Q2 | $11.1M | Sell |
109,131
-15,449
| -12% | -$1.58M | 0.03% | 555 |
|
|
2023
Q1 | $11.3M | Sell |
124,580
-20,864
| -14% | -$1.9M | 0.03% | 517 |
|
|
2022
Q4 | $5.53M | Buy |
145,444
+97,329
| +202% | +$3.7M | 0.02% | 778 |
|
|
2022
Q3 | $1.21M | Buy |
+48,115
| New | +$1.21M | ﹤0.01% | 1337 |
|
|
2022
Q1 | – | Sell |
-102,002
| Closed | -$2.69M | – | 3277 |
|
|
2021
Q4 | $2.69M | Buy |
+102,002
| New | +$2.69M | 0.01% | 1193 |
|
|
2020
Q2 | – | Sell |
-51,682
| Closed | -$7.46M | – | 2487 |
|
|
2020
Q1 | $7.46M | Buy |
+51,682
| New | +$7.46M | 0.06% | 274 |
|
|
2019
Q2 | – | Sell |
-24,147
| Closed | -$2.06M | – | 2527 |
|
|
2019
Q1 | $2.06M | Buy |
+24,147
| New | +$2.06M | 0.01% | 1138 |
|